JHS Svendgaard Laboratories Ltd Quarterly Results, Profit & Loss, Balance Sheet (JHS) | Stocksigma

JHS Svendgaard Laboratories Ltd (JHS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

JHS Svendgaard Laboratories Ltd reported sales of ₹30.38 Cr, operating profit of ₹2.07 Cr (OPM 6.81%) and net profit of ₹1.09 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.

JHS quarterly results (₹ Cr)
Metric	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	19.68	22.66	25.17	23.45	22.28	23.27	32.7	30.38
Expenses	20.52	22.41	30.55	21.79	21.37	21.6	34.34	28.31
Operating Profit	-0.84	0.25	-5.38	1.66	0.91	1.67	-1.64	2.07
OPM	-4.27%	1.1%	-21.37%	7.08%	4.08%	7.18%	-5.02%	6.81%
Other Income	0.86	0.27	-1.44	1	1.14	0.59	0.73	0.09
Interest	0.11	0.13	0.21	0.16	0.2	0.28	0.22	0.28
Depreciation	1.98	1.97	2.02	1.88	1.86	1.9	1.86	1.82
Profit before tax	-2.07	-1.58	-9.05	0.62	-0.01	0.08	-2.99	0.06
Tax	398.07%	15.82%	-23.09%	-69.35%	1,800%	-887.5%	19.73%	-1,716.67%
Net Profit	-10.32	-1.84	-6.96	1.06	-0.2	0.79	-3.57	1.09
EPS in Rs	-1.21	-0.21	-0.81	0.12	-0.02	0.09	-0.41	0.12

JHS profit & loss, annual (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	86	85	71	92	102	109
Expenses	87	94	72	96	99	106
Operating Profit	-1	-9	-1	-4	3	3
OPM	-1%	-11%	-1.3%	-4.4%	2.6%	2.8%
Other Income	9	-7	4	0	3	3
Interest	1	1	0	1	1	1
Depreciation	7	6	6	8	8	7
Profit before tax	0	-23	-3	-13	-2	-3
Tax	4,000%	-24%	18%	58%	-16%	-
Net Profit	-4	-18	-4	-20	-2	-2
EPS in Rs	-0.62	0.62	-0.52	-2.31	-0.22	-0.22
Dividend Payout	0%	0%	0%	0%	0%	-

JHS balance sheet (₹ Cr)
Metric	Mar 2023	Mar 2024	Mar 2025	Sep 2025	Mar 2026
Equity Capital	78	78	86	85.6	87
Reserves	95	91	87	88.04	87
Borrowings	3	5	6	10.59	15
Other Liabilities	52	22	25	22.67	27
Total Liabilities	228	197	204	206.9	216
Fixed Assets	65	90	90	88.32	89
CWIP	9	1	0	2.95	4
Investments	3	3	4	4.88	5
Other Assets	152	102	110	110.75	118
Total Assets	228	197	204	206.9	216

JHS cash flows (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-9	23	-9	-5	-3
Cash from Investing Activity	-5	10	-21	-20	-12
Cash from Financing Activity	-2	-1	2	23	11
Net Cash Flow	-16	32	-28	-2	-3
Free Cash Flow	-16	21	-33	-14	-15
CFO/OP	1,051%	-257%	1,001%	122%	-77%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit	1,051	-257	1,001	122	-77

JHS ratios
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	77	80	66	52	60
Inventory Days	114	128	176	151	156
Days Payable	130	197	197	140	174
Cash Conversion Cycle	61	11	46	63	42
Working Capital Days	217	41	51	47	45
ROCE	1%	-2%	-2%	-5%	-1%